STING1 and neoplasm: Intratumoral injection of the STING agonist ADU-S100 combined with radiotherapy increased tumor interferon-stimulated gene expression and T-cell infiltration, causing a reduction in local and distal tumor burden in PDAC murine models (Vonderhaar et al., 2021).